EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Successful Sequential and Additive Drug Challenge With Rapid Oral Desensitization in Rifampicin‐Induced Fever

Xin Yue Guo iD, Constantine Zois

Respirology Case Reports · 2026-05 · 14 (5)

DOI: 10.1002/rcr2.70584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respirology Case Reports, online erschienen am 01.05.2026. Verfasst von Xin Yue Guo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Sleep Medicine Prince of Wales Hospital Randwick New South Wales Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adverse drug reactions to first‐line antituberculosis (anti‐TB) therapy are common and may necessitate treatment interruption. While drug desensitization is increasingly used for delayed hypersensitivity, evidence supporting outpatient rapid oral desensitization in mild delayed reactions such as drug‐induced fever is limited. We report a 63‐year‐old man with active pulmonary tuberculosis who developed drug‐induced fever after commencing standard anti‐TB therapy. Sequential and additive drug challenge identified rifampicin as the offending agent. The patient subsequently underwent successful rapid oral rifampicin desensitization in an outpatient setting, enabling completion of 6 months of therapy without recurrence of adverse effects. This case demonstrates the feasibility of outpatient rapid oral desensitization for mild delayed hypersensitivity reactions, including drug‐induced fever. Such an approach may reduce treatment interruption and hospitalisation, particularly in settings where standardised outpatient desensitization protocols are lacking. Further studies are needed to define optimal strategies for managing mild delayed hypersensitivity reactions to anti‐TB medications.

Schlagwörter

Stichwörter der Autor:innen

antituberculosis therapydrug desensitizationhypersensitivity reactionrifampicin‐induced feversequential additive drug challenge

Autor:innen und Institutionen

  • Department of Respiratory and Sleep Medicine Prince of Wales Hospital Randwick New South Wales Australia.
  • School of Medicine and Health UNSW Sydney New South Wales Australia.

ORCID-Profile: Xin Yue Guo

Zitieren

APA

Guo, X. Y., & Zois, C. (2026). Successful Sequential and Additive Drug Challenge With Rapid Oral Desensitization in Rifampicin‐Induced Fever. Respirology Case Reports, 14(5). https://doi.org/10.1002/rcr2.70584

Vancouver

Guo XY, Zois C. Successful Sequential and Additive Drug Challenge With Rapid Oral Desensitization in Rifampicin‐Induced Fever. Respirology Case Reports. 2026;14(5). doi:10.1002/rcr2.70584

BibTeX
@article{Guo2026,
  author = {Guo, Xin Yue and Zois, Constantine},
  title = {Successful Sequential and Additive Drug Challenge With Rapid Oral Desensitization in Rifampicin‐Induced Fever},
  journal = {Respirology Case Reports},
  year = {2026},
  volume = {14},
  number = {5},
  doi = {10.1002/rcr2.70584}
}
Kostenlos starten →